APP and Alzheimer disease: Yi et al. (2025) reported that ELK1 knockdown or inhibiting its activation via an interfering peptide decreased amyloidogenic processing of APP, consequently reducing the generation of Aβ in APP23/PS45 double-transgenic AD animals [41].